Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance.
Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance. Pharmacol Rep. 2007 Jul-Aug; 59(4):428-36.
View in:
PubMed
subject areas
Acetophenones
Acetophenones
Adenosine Diphosphate
Adenosine Diphosphate
Administration, Oral
Administration, Oral
Aged
Aged
Aspirin
Aspirin
Blotting, Western
Blotting, Western
Collagen
Collagen
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Drug Resistance
Drug Resistance
Enzyme Inhibitors
Enzyme Inhibitors
Female
Female
Heart Diseases
Heart Diseases
Humans
Humans
Luminescent Measurements
Luminescent Measurements
Male
Male
Membrane Glycoproteins
Membrane Glycoproteins
Middle Aged
Middle Aged
NADPH Oxidase 2
NADPH Oxidase 2
NADPH Oxidases
NADPH Oxidases
Onium Compounds
Onium Compounds
Phosphoproteins
Phosphoproteins
Platelet Aggregation
Platelet Aggregation
Platelet Function Tests
Platelet Function Tests
Platelet-Rich Plasma
Platelet-Rich Plasma
authors with profiles
Anna Csiszar
Zoltan Ungvari